AQR Capital Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Buy
145,575
+14,066
+11% +$152K ﹤0.01% 2554
2025
Q4
$1.4M Sell
131,509
-179,310
-58% -$2.15M ﹤0.01% 2359
2025
Q3
$4.25M Buy
310,819
+90,688
+41% +$1.27M ﹤0.01% 1552
2025
Q2
$3.09M Buy
220,131
+20,381
+10% +$268K ﹤0.01% 1536
2025
Q1
$2.69M Buy
199,750
+25,366
+15% +$381K ﹤0.01% 1451
2024
Q4
$3.07M Sell
174,384
-210,214
-55% -$3.9M ﹤0.01% 1304
2024
Q3
$7.36M Sell
384,598
-5,353
-1% -$103K 0.01% 899
2024
Q2
$8.51M Buy
389,951
+210,669
+118% +$5.62M 0.01% 811
2024
Q1
$6.87M Buy
179,282
+68,866
+62% +$3.34M 0.01% 858
2023
Q4
$7.42M Sell
110,416
-11,255
-9% -$784K 0.01% 807
2023
Q3
$9.11M Buy
121,671
+19,192
+19% +$1.7M 0.02% 702
2023
Q2
$9.44M Buy
102,479
+21,927
+27% +$1.95M 0.02% 682
2023
Q1
$8.35M Buy
80,552
+38,969
+94% +$4.32M 0.02% 703
2022
Q4
$4.8M Buy
41,583
+29,369
+240% +$3.42M 0.01% 914
2022
Q3
$1.32M Buy
12,214
+8,030
+192% +$1.15M ﹤0.01% 1394
2022
Q2
$755K Sell
4,184
-3,952
-49% -$707K ﹤0.01% 1531
2022
Q1
$1.39M Sell
8,136
-3,640
-31% -$686K ﹤0.01% 1377
2021
Q4
$2.47M Sell
11,776
-783
-6% -$162K ﹤0.01% 1060
2021
Q3
$2.42M Sell
12,559
-1,880
-13% -$462K ﹤0.01% 1045
2021
Q2
$4.09M Buy
14,439
+1,473
+11% +$399K 0.01% 892
2021
Q1
$2.75M Sell
12,966
-762
-6% -$182K ﹤0.01% 1042
2020
Q4
$2.69M Buy
13,728
+4,566
+50% +$807K ﹤0.01% 1022
2020
Q3
$1.51M Buy
9,162
+6,811
+290% +$1.12M ﹤0.01% 1231
2020
Q2
$326K Buy
+2,351
New +$216K ﹤0.01% 1871
2020
Q1
Sell
-10,853
Closed -$1.19M 2112
2019
Q4
$1.19M Sell
10,853
-76,992
-88% -$7.45M ﹤0.01% 1455
2019
Q3
$9.1M Sell
87,845
-17,043
-16% -$1.83M 0.01% 791
2019
Q2
$13.5M Sell
104,888
-18,882
-15% -$2.62M 0.02% 692
2019
Q1
$15.8M Sell
123,770
-8,101
-6% -$1.03M 0.02% 655
2018
Q4
$16.5M Sell
131,871
-261
-0.2% -$44.6K 0.02% 593
2018
Q3
$29.3M Buy
132,132
+77,097
+140% +$15.6M 0.03% 506
2018
Q2
$8.81M Buy
55,035
+39,269
+249% +$5.02M 0.01% 827
2018
Q1
$1.47M Sell
15,766
-12,003
-43% -$897K ﹤0.01% 1495
2017
Q4
$1.94M Sell
27,769
-13,054
-32% -$866K ﹤0.01% 1390
2017
Q3
$2.42M Sell
40,823
-56,378
-58% -$2.81M ﹤0.01% 1311
2017
Q2
$4.03M Sell
97,201
-22,494
-19% -$978K 0.01% 1112
2017
Q1
$5.31M Sell
119,695
-13,036
-10% -$561K 0.01% 1003
2016
Q4
$5.53M Sell
132,731
-2,562
-2% -$103K 0.01% 1003
2016
Q3
$5.11M Buy
135,293
+23,753
+21% +$851K 0.01% 996
2016
Q2
$3.71M Sell
111,540
-2,646
-2% -$85.4K 0.01% 1024
2016
Q1
$3.45M Sell
114,186
-3,911
-3% -$114K 0.01% 1015
2015
Q4
$3.59M Sell
118,097
-8,939
-7% -$266K 0.01% 1018
2015
Q3
$3.41M Sell
127,036
-26,071
-17% -$759K 0.01% 923
2015
Q2
$4.95M Sell
153,107
-8,883
-5% -$282K 0.01% 839
2015
Q1
$4.86M Buy
161,990
+17,227
+12% +$547K 0.01% 791
2014
Q4
$4.86M Buy
144,763
+57,022
+65% +$1.78M 0.01% 921
2014
Q3
$2.88M Buy
87,741
+3,700
+4% +$114K 0.01% 1075
2014
Q2
$2.56M Sell
84,041
-49,300
-37% -$1.54M 0.01% 1176
2014
Q1
$3.88M Sell
133,341
-2,000
-1% -$53.6K 0.01% 958
2013
Q4
$3.54M Sell
135,341
-19,000
-12% -$487K 0.01% 1036
2013
Q3
$4.15M Sell
154,341
-30,262
-16% -$809K 0.01% 898
2013
Q2
$4.75M Buy
+184,603
New +$4.85M 0.02% 889

Other funds holding MED

AQR Capital Management's MED Position: Q1 2026 in Review

AQR Capital Management increased its Medifast (MED) stake by 11% in Q1 2026, buying an estimated $152K and bringing the position to 145,575 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2554.

AQR Capital Management first reported a position in MED in Q2 2013 and has held it in 51 quarters since. The position peaked at $29.3M in Q3 2018. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • AQR Capital Management held 145,575 shares of Medifast worth $1.48M as of Q1 2026.
  • AQR Capital Management bought 14,066 Medifast shares in Q1 2026, an estimated $152K.
  • Medifast made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2554 holding.
  • AQR Capital Management first reported a position in Medifast in Q2 2013 and has held it in 51 quarters since.
  • AQR Capital Management's Medifast position peaked at $29.3M in Q3 2018.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.